New dual-curing potting compound for piezoceramics

Vitralit® UD 8052 F is a low viscosity, one-component UV curable adhesive. It is jettable, transparent, and fluoresces under UV light. Customized versions with different colors are available to facilitate improved process control. Its jet dispense capability makes high UPH (units per hour) values achievable, which is why Vitralit® UD 8052 F is the perfect choice for consumer electronics applications.

This potting compound can be cured in just a few seconds with UV light (320nm - 390nm) or visible light (405nm). The fluorescing adhesive allows in-line process control with short-wave light for maximum productivity. In areas that cannot be reached by light, Vitralit® UD 8052 F post cures with atmospheric moisture, and thus polymerizes reliably into a flexible potting and glob top compound.

Its high tear resistance after curing has been optimized for bonding ceramic components to plastic, compensating for the different expansion coefficients of the bonded materials. Thus Vitralit® UD 8052 F is particularly suitable as a protective coating and for applications subject to tensile and compressive stresses. As a potting compound, it features a low halogen content, is flexible, and offers protection against corrosion and other environmental influences.  

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Panacol-Elosol GmbH. (2020, November 23). New dual-curing potting compound for piezoceramics. AZoM. Retrieved on October 12, 2024 from https://www.azom.com/news.aspx?newsID=55041.

  • MLA

    Panacol-Elosol GmbH. "New dual-curing potting compound for piezoceramics". AZoM. 12 October 2024. <https://www.azom.com/news.aspx?newsID=55041>.

  • Chicago

    Panacol-Elosol GmbH. "New dual-curing potting compound for piezoceramics". AZoM. https://www.azom.com/news.aspx?newsID=55041. (accessed October 12, 2024).

  • Harvard

    Panacol-Elosol GmbH. 2020. New dual-curing potting compound for piezoceramics. AZoM, viewed 12 October 2024, https://www.azom.com/news.aspx?newsID=55041.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.